Evaluation of percutaneous absorption and skin irritation of ketoprofen through rat skin: in vitro and in vivo study

被引:30
作者
Wu, PC
Chang, JS
Huang, YB
Chai, CY
Tsai, YH
机构
[1] Kaohsiung Med Univ, Sch Pharm, Kaohsiung 807, Taiwan
[2] Kaohsiung Med Univ, Dept Pathol, Kaohsiung, Taiwan
关键词
ketoprofen; azone; nonivamide; irritation; colorimetry;
D O I
10.1016/S0378-5173(01)00707-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The influences of different mechanisms of penetration enhancers (such as menthol, atone, ethanol and nonivarnide) regarding the percutaneous absorption and skin irritation of ketoprofen formulations through rat skin were investigated by in vitro and in vivo study. The skin irritation degree at the end of the experiment (10 h) was determined by pathologic biopsy and colorimetry methods. In vitro, the menthol showed the most potent enhancing effect. Furthermore, the enhancement effect of a combination of menthol and nonivamide was higher than that of their individual use alone. In vivo the formulation containing 0.05% nonivantide, 5% menthol and 20% ethanol showed a higher penetration rate and an acceptable degree of skin irritation compared to a commercial product (Formax plus((R)) gel containing 3% ketoprofen), indicating that it could be used in the clinical situation. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:225 / 235
页数:11
相关论文
共 34 条
[1]  
AKHTER SA, 1984, J PHARM PHARM S, V36, P7
[2]   QUANTITATIVE SKIN BLANCHING ASSAY OF CORTICOSTEROID CREAMS USING TRISTIMULUS COLOR ANALYSIS [J].
CHAN, SY ;
PO, ALW .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1992, 44 (05) :371-378
[3]   The effects of Azone and capsaicin on the permeation of naproxen through human skin [J].
Degim, IT ;
Uslu, A ;
Hadgraft, J ;
Atay, T ;
Akay, C ;
Cevheroglu, S .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 179 (01) :21-25
[4]   In vitro permeation study of capsaicin and its synthetic derivatives from ointment bases using various skin types [J].
Fang, JY ;
Wu, PC ;
Huang, YB ;
Tsai, YH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 126 (1-2) :119-128
[5]  
Fang JY, 1997, DRUG DEVELOP RES, V40, P56, DOI 10.1002/(SICI)1098-2299(199701)40:1<56::AID-DDR6>3.0.CO
[6]  
2-S
[7]   Topical EMLA® pre-treatment fails to decrease the pain induced by 1% topical capsaicin [J].
Fuchs, PN ;
Pappagallo, M ;
Meyer, RA .
PAIN, 1999, 80 (03) :637-642
[8]  
GAMES R, 1982, ARCH PHARM, V32, P205
[9]   A PHARMACOKINETIC MODEL FOR PERCUTANEOUS-ABSORPTION [J].
GUY, RH ;
HADGRAFT, J ;
MAIBACH, HI .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1982, 11 (02) :119-129
[10]   THE DEPOLARIZING ACTION OF CAPSAICIN ON RAT ISOLATED SCIATIC-NERVE [J].
HAYES, AG ;
HAWCOCK, AB ;
HILL, RG .
LIFE SCIENCES, 1984, 35 (15) :1561-1568